YBMN ETF — Defiance BioMarin Option Income ETF
Defiance BioMarin Option Income ETF (YBMN)
YBMN is an ETF that tracks the BioMarin Pharmaceutical (BMRN). As of August 19, 2026, its distribution rate is 54.13%, its trailing-12-month yield is 53.92%, its expense ratio is 0.85%. Dividend Vision Distribution Safety Score™ is 36/100 (Elevated risk). Fund total return is -19.4% over the past 0.7 years, 38.4 points behind BMRN at 19.0%.
At the current 54.13% distribution rate, a $10,000 investment would generate approximately $5,413 per year, or $451.08 per month on an equivalent basis. Actual weekly payments vary.
YBMN dividend yield and income
Data as of August 19, 2026.
The distribution rate (54.13%) is the latest posted forward yield, paid weekly. Trailing-12-month yield (53.92%) is the last year of payments divided by the current price. The 30-day SEC yield is 2.01%. The last dividend was $0.1310. The last ex-dividend date was 08/12/2026. It was paid on 08/13/2026. At 54.13%, $10,000 would generate about $5,413 a year ($451.08 monthly-equivalent).
| Ex-date | Amount | vs year-ago payment |
|---|---|---|
| 2026-08-12 | $0.131 | — |
| 2026-08-05 | $0.109 | — |
| 2026-07-29 | $0.105 | — |
| 2026-07-22 | $0.103 | — |
| 2026-07-15 | $0.104 | — |
| 2026-07-08 | $0.134 | — |
| 2026-07-01 | $0.156 | — |
| 2026-06-24 | $0.09 | — |
| 2026-06-17 | $0.143 | — |
| 2026-06-10 | $0.077 | — |
| 2026-06-03 | $0.117 | — |
| 2026-05-27 | $0.206 | — |
| 2026-05-20 | $0.198 | — |
| 2026-05-13 | $0.205 | — |
| 2026-05-06 | $0.221 | — |
| 2026-04-29 | $0.143 | — |
| 2026-04-22 | $0.14 | — |
| 2026-04-15 | $0.141 | — |
| 2026-04-08 | $0.149 | — |
| 2026-04-01 | $0.189 | — |
| 2026-03-25 | $0.167 | — |
| 2026-03-18 | $0.18 | — |
| 2026-03-11 | $0.123 | — |
| 2026-03-04 | $0.14 | — |
| 2026-02-25 | $0.101 | — |
| 2026-02-18 | $0.107 | — |
| 2026-02-11 | $0.215 | — |
| 2026-02-04 | $0.204 | — |
| 2026-01-28 | $0.341 | — |
| 2026-01-21 | $0.369 | — |
| 2026-01-14 | $0.275 | — |
| 2026-01-07 | $0.243 | — |
| 2025-12-31 | $0.246 | — |
| 2025-12-24 | $0.464 | — |
| 2025-12-17 | $0.448 | — |
| 2025-12-10 | $0.187 | — |
| 2025-12-03 | $0.115 | — |
| 2025 total | $1.46 | — |
| 2026 YTD total | $5.326 | — |
YBMN dividend growth
An annualized trend fit on recent payments is -98.06%. That fit can move with uneven quarterly amounts and is not the same as a trailing-12-month cut.
YBMN performance versus BMRN
Data as of August 19, 2026.
Fund total return is -19.4% over the past 0.7 years, 38.4 points behind BMRN at 19.0%.
| Window | Total return | CAGR |
|---|---|---|
| Since inception (0.7 years) | -19.4% | — |
YBMN key facts
Data as of August 19, 2026.
- Distribution Safety Score™
- 36 · Elevated risk
- Safety-Adjusted Yield
- 19.49%
- Issuer
- Defiance ETFs
- Asset type
- ETF
- Asset class
- Equity
- Inception date
- 11/24/2025
- Expense ratio
- 0.85%
- Distribution rate
- 54.13%
- Distribution frequency
- Weekly
- Trailing yield
- 53.92%
- 30-day SEC yield
- 2.01%
- Last close
- $12.59
- AUM
- $3,149,410
- Average volume
- 5163.0
- Last dividend
- $0.1310
- Ex-dividend date
- 08/12/2026
- Payment date
- 08/13/2026
- Beta
- 3.713
How Dividend Vision calculates yield and returns
Distribution rate (54.13%) is the latest regular payout annualized by the fund's stated frequency, divided by the last close. Issuers often publish this as “Distribution Rate” on the fact sheet. Trailing-12-month yield (53.92%) is the sum of distributions paid in the last 12 months, split-adjusted, divided by the last close. It lags a recent raise or cut. The 30-day SEC yield (2.01%) is the SEC standardized figure when we have it. An issuer may publish a different SEC or TTM yield using another as-of date or share-class convention. Fund total return uses split-adjusted close with distributions reinvested from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is what the fund did, not your personal gain/loss. Figures below use Dividend Vision data as of August 19, 2026.
Distribution rate methodology · Distribution Safety Score methodology · SEC yield
Sources and review
Data as of August 19, 2026.
Primary sources: Defiance ETFs fund page; Index: BioMarin Pharmaceutical (BMRN); prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
YBMN risks and drawbacks
Total return has trailed BMRN over the available window.
Who may consider YBMN — and who may not
It is a weaker fit for investors whose main goal is matching BMRN total return. This is educational context, not a recommendation to buy or sell.
Frequently asked questions
Does YBMN pay monthly?
No. YBMN currently pays weekly, not monthly.
What index does YBMN track?
YBMN tracks the BioMarin Pharmaceutical (BMRN).
What is YBMN's expense ratio?
YBMN's expense ratio is 0.85%.
What is YBMN's dividend yield?
YBMN currently yields 54.13%, paid weekly, with a 0.85% expense ratio.
When does YBMN pay a dividend?
YBMN pays weekly. The last dividend was $0.1310. The last ex-dividend date was 08/12/2026. It was paid on 08/13/2026.
How has YBMN performed?
Fund total return is -19.4% over the past 0.7 years, 38.4 points behind BMRN at 19.0%.
Is YBMN a good investment?
YBMN's Dividend Vision Distribution Safety Score is 36 (Elevated risk). That is a risk signal, not investment advice. It currently yields 54.13%. Compare peers below rather than treating any single figure as a buy or sell.
More funds from Defiance ETFs.
Tickers
| Ticker | Name | Weight |
|---|